📈 Fed's first cut since 2020: Time to buy the dip? See Tech-focused stock picksUnlock AI Picks

Clinuvel Pharmaceuticals Ltd ADR (CLVLY)

OTC Markets
Currency in USD
Disclaimer
10.000
0.000(0.00%)
Delayed Data
CLVLY Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
10.00010.000
52 wk Range
8.42012.060
Prev. Close
10
Open
10
Day's Range
10-10
52 wk Range
8.42-12.06
Volume
0
Average Volume (3m)
1,679
1-Year Change
-6.54%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
CLVLY Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Clinuvel Pharmaceuticals Ltd ADR Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company’s pipeline products include CUV9900 and Parvysmelanotide (VLRX001), both alpha-melanocyte stimulating hormone analogue; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. It is also developing NEURACTHEL (ACTH), an adrenocorticotropic hormone to produce cortisol and enables the combat of stress and regulation of immune responses, maintenance of blood pressure, moderation of blood sugar, and regulation of metabolism. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.

Employees
0

Compare CLVLY to Peers and Sector

Metrics to compare
CLVLY
Peers
Sector
Relationship
P/E Ratio
21.6x−3.8x−0.6x
PEG Ratio
1.210.010.00
Price/Book
3.8x4.9x2.6x
Price / LTM Sales
8.7x9.5x3.1x
Upside (Analyst Target)
-156.8%55.8%
Fair Value Upside
Unlock−0.5%7.3%Unlock

FAQ

What Is the Clinuvel Pharmaceuticals ADR (CLVLY) Stock Price Today?

The Clinuvel Pharmaceuticals ADR stock price today is 10.00

What Stock Exchange Does Clinuvel Pharmaceuticals ADR Trade On?

Clinuvel Pharmaceuticals ADR is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Clinuvel Pharmaceuticals ADR?

The stock symbol for Clinuvel Pharmaceuticals ADR is "CLVLY."

Does Clinuvel Pharmaceuticals ADR Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.30%.

What Is the Clinuvel Pharmaceuticals ADR Market Cap?

As of today, Clinuvel Pharmaceuticals ADR market cap is 508.67M.

What is Clinuvel Pharmaceuticals ADR Earnings Per Share?

The Clinuvel Pharmaceuticals ADR EPS is 0.715.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.